Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

Osteoporosis International

Volumn 20, Issue 6, 2009, Pages 943-948

  Lindsay, R ^a   Miller, P ^b   Pohl, G ^c   Glass, E V ^c   Chen, P ^c   Krege, J H ^c  

^a HELEN HAYES HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Back pain; Nonvertebral fracture; Osteoporosis; Parathyroid hormone; Postmenopausal women; Teriparatide

Indexed keywords

CALCIUM; PARATHYROID HORMONE[1-34]; VITAMIN D;

ADULT; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIZZINESS; DRUG EFFECT; FEMALE; FRAGILITY FRACTURE; HEADACHE; HUMAN; LEG CRAMP; MAJOR CLINICAL STUDY; NAUSEA; OSTEOPOROSIS; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; TREATMENT DURATION;

BACK PAIN; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; SPINAL FRACTURES; TERIPARATIDE; TREATMENT OUTCOME;

EID: 67349206106     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0766-0     Document Type: Article

References (17)

1. R Lindsay J Nieves C Formica 1997 Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis Lancet 350 550 555
2. JS Finkelstein A Hayes JL Hunzelman 2003 The effects of parathyroid hormone, alendronate, or both in men with osteoporosis N Engl J Med 249 1216 1226
3. RM Neer CD Arnaud JR Zanchetta 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434 1441
4. HK Genant CY Wu C van Kuijk MC Nevitt 1993 Vertebral fracture assessment using a semiquantitative technique J Bone Miner Res 8 1137 1148
5. Cox DR, Oakes D (2001) Analysis of survival data. Chapman and Hall, London, England
6. JJ Caro KJ Ishak KF Huybrechts 2004 The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 12 1003 1008
7. YL Ma Q Zeng DW Donley 2006 Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis J Bone Miner Res 21 6 855 864
8. Y Jiang JJ Zhao BH Mitlak 2003 Teriparatide [recombinant human parathyroid hormone (1-34)] improves both cortical and cancellous bone structure J Bone Miner Res 18 1932 1941
9. DW Dempster F Cosman ES Kurland 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study J Bone Miner Res 16 1846 1853
10. J Reeve PJ Meunier JA Parsons 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial BMJ 280 1340 1344
11. JN Bradbeer ME Arlot PJ Meunier 1992 Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone Clin Endocrinol 37 282 289
12. AB Hodsman BM Steer 1993 Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces Bone 14 523 527
13. DW Dempster H Zhou F Cosman 2001 PTH treatment directly stimulates bone formation in cancellous and cortical bone in humans J Bone Miner Res 16 Suppl 1 S179
14. HK Genant J Halse WG Briney 2005 The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis Curr Med Res Opin 21 7 1027 1034
15. MC Nevitt P Chen RK Dore 2006 Reduced risk of back pain following teriparatide treatment: a meta-analysis Osteoporos Int 17 2 273 280
16. MC Nevitt P Chen DP Kiel 2006 Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis Osteoporos Int 17 11 1630 1637
17. R Lindsay WH Scheele RM Neer 2004 Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis Arch Intern Med 164 18 2024 2030